Genomics

Dataset Information

Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy.


ABSTRACT: Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy.

PROVIDER: PRJNA1139138 | ENA |

REPOSITORIES: ENA